Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis
Wegener's granulomatosis initially affects upper respiratory tract organs including the nasal mucosa in more than 90% of patients. The inflammation is typically granulomatous with associated vasculitis. T lymphocytes are usually a prominent component of the leucocyte infiltrate. Previous studie...
Gespeichert in:
Veröffentlicht in: | Clinical and experimental immunology 2001-08, Vol.125 (2), p.332-339 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 339 |
---|---|
container_issue | 2 |
container_start_page | 332 |
container_title | Clinical and experimental immunology |
container_volume | 125 |
creator | Balding, C. E. J. Howie, A. J. Drake‐Lee, A. B. Savage, C. O. S. |
description | Wegener's granulomatosis initially affects upper respiratory tract organs including the nasal mucosa in more than 90% of patients. The inflammation is typically granulomatous with associated vasculitis. T lymphocytes are usually a prominent component of the leucocyte infiltrate. Previous studies using peripheral blood T cells have implicated IFN‐γ rich Th1‐type responses. This study addressed the cytokine milieu in nasal mucosa from 10 patients with active Wegener's granulomatosis using immunohistochemistry. Increased levels of CD3+ T cells and eosinophils were present compared with normal and disease controls. There was increased expression of IL‐4, down‐regulation of IL‐2 and no detectable IFN‐γ. There was increased expression of the chemokine receptor CCR3 by infiltrating cells, consistent with an IL‐4 dominant, Th2‐biased response. In contrast, renal biopsy tissue from 10 patients with active Wegener's granulomatosis showed expression of IL‐2 and IL‐4. The Th2‐type environment within nasal mucosa, often the initial site of disease activity in Wegener's, is consistent with a local allergic response in these patients. |
doi_str_mv | 10.1046/j.1365-2249.2001.125002332.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1906130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18140346</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5744-efcd63abd8a41d5c63352a086e3be0e37ffdfce5d3c85bcf1626af7dadbb53aa3</originalsourceid><addsrcrecordid>eNqVkc9u1DAQhy0EokvhFVCEoLcE_08iIaRqVWClSlyKOFoTx9n1KrEXO6Htjdfo6_EkON3VFrggTtbI3_xm7A-h1wQXBHP5dlsQJkVOKa8LijEpCBUYU8ZocfMILY6Xj9ECY1zndeo6Qc9i3KZSSkmfohNCBK1rWi7Q6mpDs9YP1oHTJrMucxChz4ZJ-whzvYPRGjfG7NqOm-yrWRtnws8fdzFbB3BT7wcYfbTxOXrSQR_Ni8N5ir58uLhafsovP39cLc8vcy1KznPT6VYyaNoKOGmFlowJCriShjUGG1Z2XdtpI1qmK9HojkgqoStbaJtGMAB2it7vc3dTM5hWp90C9GoX7ADhVnmw6s8bZzdq7b8rUmNJGE4BZ4eA4L9NJo5qsFGbvgdn_BRVSQitpRD_BElFOGZcJvDVX-DWT8GlX0hDZVWX_D7t3R7SwccYTHdcmWA1m1VbNctTszw1m1VHs-omtb_8_dkPzQeVCXhzACBq6LskR9v4wPE0Q9xz53vu2vbm9r-WUMuLFRGSs18Pa8Ki</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>196897455</pqid></control><display><type>article</type><title>Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Balding, C. E. J. ; Howie, A. J. ; Drake‐Lee, A. B. ; Savage, C. O. S.</creator><creatorcontrib>Balding, C. E. J. ; Howie, A. J. ; Drake‐Lee, A. B. ; Savage, C. O. S.</creatorcontrib><description>Wegener's granulomatosis initially affects upper respiratory tract organs including the nasal mucosa in more than 90% of patients. The inflammation is typically granulomatous with associated vasculitis. T lymphocytes are usually a prominent component of the leucocyte infiltrate. Previous studies using peripheral blood T cells have implicated IFN‐γ rich Th1‐type responses. This study addressed the cytokine milieu in nasal mucosa from 10 patients with active Wegener's granulomatosis using immunohistochemistry. Increased levels of CD3+ T cells and eosinophils were present compared with normal and disease controls. There was increased expression of IL‐4, down‐regulation of IL‐2 and no detectable IFN‐γ. There was increased expression of the chemokine receptor CCR3 by infiltrating cells, consistent with an IL‐4 dominant, Th2‐biased response. In contrast, renal biopsy tissue from 10 patients with active Wegener's granulomatosis showed expression of IL‐2 and IL‐4. The Th2‐type environment within nasal mucosa, often the initial site of disease activity in Wegener's, is consistent with a local allergic response in these patients.</description><identifier>ISSN: 0009-9104</identifier><identifier>EISSN: 1365-2249</identifier><identifier>DOI: 10.1046/j.1365-2249.2001.125002332.x</identifier><identifier>PMID: 11529927</identifier><identifier>CODEN: CEXIAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; Biopsy ; CD3 Complex - analysis ; CD3 Complex - immunology ; Cells, Cultured ; cytokines ; Cytokines - biosynthesis ; Cytokines - genetics ; Cytokines - immunology ; Female ; Granulomatosis with Polyangiitis - immunology ; Granulomatosis with Polyangiitis - pathology ; Humans ; Immunity, Mucosal ; Immunohistochemistry ; kidney ; Kidney - immunology ; Kidney - pathology ; Male ; Medical sciences ; Middle Aged ; Myeloblastin ; Nasal Mucosa - immunology ; Nasal Mucosa - pathology ; Rheumatic Disease/Vasculitis ; RNA, Messenger - biosynthesis ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Serine Endopeptidases - pharmacology ; Th1 Cells - drug effects ; Th1 Cells - immunology ; Th2 Cells - drug effects ; Th2 Cells - immunology ; vasculitis</subject><ispartof>Clinical and experimental immunology, 2001-08, Vol.125 (2), p.332-339</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. Aug 2001</rights><rights>2001 Blackwell Science Ltd 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5744-efcd63abd8a41d5c63352a086e3be0e37ffdfce5d3c85bcf1626af7dadbb53aa3</citedby><cites>FETCH-LOGICAL-c5744-efcd63abd8a41d5c63352a086e3be0e37ffdfce5d3c85bcf1626af7dadbb53aa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906130/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906130/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14104527$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11529927$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Balding, C. E. J.</creatorcontrib><creatorcontrib>Howie, A. J.</creatorcontrib><creatorcontrib>Drake‐Lee, A. B.</creatorcontrib><creatorcontrib>Savage, C. O. S.</creatorcontrib><title>Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis</title><title>Clinical and experimental immunology</title><addtitle>Clin Exp Immunol</addtitle><description>Wegener's granulomatosis initially affects upper respiratory tract organs including the nasal mucosa in more than 90% of patients. The inflammation is typically granulomatous with associated vasculitis. T lymphocytes are usually a prominent component of the leucocyte infiltrate. Previous studies using peripheral blood T cells have implicated IFN‐γ rich Th1‐type responses. This study addressed the cytokine milieu in nasal mucosa from 10 patients with active Wegener's granulomatosis using immunohistochemistry. Increased levels of CD3+ T cells and eosinophils were present compared with normal and disease controls. There was increased expression of IL‐4, down‐regulation of IL‐2 and no detectable IFN‐γ. There was increased expression of the chemokine receptor CCR3 by infiltrating cells, consistent with an IL‐4 dominant, Th2‐biased response. In contrast, renal biopsy tissue from 10 patients with active Wegener's granulomatosis showed expression of IL‐2 and IL‐4. The Th2‐type environment within nasal mucosa, often the initial site of disease activity in Wegener's, is consistent with a local allergic response in these patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>CD3 Complex - analysis</subject><subject>CD3 Complex - immunology</subject><subject>Cells, Cultured</subject><subject>cytokines</subject><subject>Cytokines - biosynthesis</subject><subject>Cytokines - genetics</subject><subject>Cytokines - immunology</subject><subject>Female</subject><subject>Granulomatosis with Polyangiitis - immunology</subject><subject>Granulomatosis with Polyangiitis - pathology</subject><subject>Humans</subject><subject>Immunity, Mucosal</subject><subject>Immunohistochemistry</subject><subject>kidney</subject><subject>Kidney - immunology</subject><subject>Kidney - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myeloblastin</subject><subject>Nasal Mucosa - immunology</subject><subject>Nasal Mucosa - pathology</subject><subject>Rheumatic Disease/Vasculitis</subject><subject>RNA, Messenger - biosynthesis</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Serine Endopeptidases - pharmacology</subject><subject>Th1 Cells - drug effects</subject><subject>Th1 Cells - immunology</subject><subject>Th2 Cells - drug effects</subject><subject>Th2 Cells - immunology</subject><subject>vasculitis</subject><issn>0009-9104</issn><issn>1365-2249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkc9u1DAQhy0EokvhFVCEoLcE_08iIaRqVWClSlyKOFoTx9n1KrEXO6Htjdfo6_EkON3VFrggTtbI3_xm7A-h1wQXBHP5dlsQJkVOKa8LijEpCBUYU8ZocfMILY6Xj9ECY1zndeo6Qc9i3KZSSkmfohNCBK1rWi7Q6mpDs9YP1oHTJrMucxChz4ZJ-whzvYPRGjfG7NqOm-yrWRtnws8fdzFbB3BT7wcYfbTxOXrSQR_Ni8N5ir58uLhafsovP39cLc8vcy1KznPT6VYyaNoKOGmFlowJCriShjUGG1Z2XdtpI1qmK9HojkgqoStbaJtGMAB2it7vc3dTM5hWp90C9GoX7ADhVnmw6s8bZzdq7b8rUmNJGE4BZ4eA4L9NJo5qsFGbvgdn_BRVSQitpRD_BElFOGZcJvDVX-DWT8GlX0hDZVWX_D7t3R7SwccYTHdcmWA1m1VbNctTszw1m1VHs-omtb_8_dkPzQeVCXhzACBq6LskR9v4wPE0Q9xz53vu2vbm9r-WUMuLFRGSs18Pa8Ki</recordid><startdate>200108</startdate><enddate>200108</enddate><creator>Balding, C. E. J.</creator><creator>Howie, A. J.</creator><creator>Drake‐Lee, A. B.</creator><creator>Savage, C. O. S.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Oxford University Press</general><general>Blackwell Science Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200108</creationdate><title>Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis</title><author>Balding, C. E. J. ; Howie, A. J. ; Drake‐Lee, A. B. ; Savage, C. O. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5744-efcd63abd8a41d5c63352a086e3be0e37ffdfce5d3c85bcf1626af7dadbb53aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>CD3 Complex - analysis</topic><topic>CD3 Complex - immunology</topic><topic>Cells, Cultured</topic><topic>cytokines</topic><topic>Cytokines - biosynthesis</topic><topic>Cytokines - genetics</topic><topic>Cytokines - immunology</topic><topic>Female</topic><topic>Granulomatosis with Polyangiitis - immunology</topic><topic>Granulomatosis with Polyangiitis - pathology</topic><topic>Humans</topic><topic>Immunity, Mucosal</topic><topic>Immunohistochemistry</topic><topic>kidney</topic><topic>Kidney - immunology</topic><topic>Kidney - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myeloblastin</topic><topic>Nasal Mucosa - immunology</topic><topic>Nasal Mucosa - pathology</topic><topic>Rheumatic Disease/Vasculitis</topic><topic>RNA, Messenger - biosynthesis</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Serine Endopeptidases - pharmacology</topic><topic>Th1 Cells - drug effects</topic><topic>Th1 Cells - immunology</topic><topic>Th2 Cells - drug effects</topic><topic>Th2 Cells - immunology</topic><topic>vasculitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balding, C. E. J.</creatorcontrib><creatorcontrib>Howie, A. J.</creatorcontrib><creatorcontrib>Drake‐Lee, A. B.</creatorcontrib><creatorcontrib>Savage, C. O. S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and experimental immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balding, C. E. J.</au><au>Howie, A. J.</au><au>Drake‐Lee, A. B.</au><au>Savage, C. O. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis</atitle><jtitle>Clinical and experimental immunology</jtitle><addtitle>Clin Exp Immunol</addtitle><date>2001-08</date><risdate>2001</risdate><volume>125</volume><issue>2</issue><spage>332</spage><epage>339</epage><pages>332-339</pages><issn>0009-9104</issn><eissn>1365-2249</eissn><coden>CEXIAL</coden><abstract>Wegener's granulomatosis initially affects upper respiratory tract organs including the nasal mucosa in more than 90% of patients. The inflammation is typically granulomatous with associated vasculitis. T lymphocytes are usually a prominent component of the leucocyte infiltrate. Previous studies using peripheral blood T cells have implicated IFN‐γ rich Th1‐type responses. This study addressed the cytokine milieu in nasal mucosa from 10 patients with active Wegener's granulomatosis using immunohistochemistry. Increased levels of CD3+ T cells and eosinophils were present compared with normal and disease controls. There was increased expression of IL‐4, down‐regulation of IL‐2 and no detectable IFN‐γ. There was increased expression of the chemokine receptor CCR3 by infiltrating cells, consistent with an IL‐4 dominant, Th2‐biased response. In contrast, renal biopsy tissue from 10 patients with active Wegener's granulomatosis showed expression of IL‐2 and IL‐4. The Th2‐type environment within nasal mucosa, often the initial site of disease activity in Wegener's, is consistent with a local allergic response in these patients.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>11529927</pmid><doi>10.1046/j.1365-2249.2001.125002332.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-9104 |
ispartof | Clinical and experimental immunology, 2001-08, Vol.125 (2), p.332-339 |
issn | 0009-9104 1365-2249 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1906130 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adolescent Adult Aged Biological and medical sciences Biopsy CD3 Complex - analysis CD3 Complex - immunology Cells, Cultured cytokines Cytokines - biosynthesis Cytokines - genetics Cytokines - immunology Female Granulomatosis with Polyangiitis - immunology Granulomatosis with Polyangiitis - pathology Humans Immunity, Mucosal Immunohistochemistry kidney Kidney - immunology Kidney - pathology Male Medical sciences Middle Aged Myeloblastin Nasal Mucosa - immunology Nasal Mucosa - pathology Rheumatic Disease/Vasculitis RNA, Messenger - biosynthesis Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Serine Endopeptidases - pharmacology Th1 Cells - drug effects Th1 Cells - immunology Th2 Cells - drug effects Th2 Cells - immunology vasculitis |
title | Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T00%3A31%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Th2%20dominance%20in%20nasal%20mucosa%20in%20patients%20with%20Wegener%E2%80%99s%20granulomatosis&rft.jtitle=Clinical%20and%20experimental%20immunology&rft.au=Balding,%20C.%20E.%20J.&rft.date=2001-08&rft.volume=125&rft.issue=2&rft.spage=332&rft.epage=339&rft.pages=332-339&rft.issn=0009-9104&rft.eissn=1365-2249&rft.coden=CEXIAL&rft_id=info:doi/10.1046/j.1365-2249.2001.125002332.x&rft_dat=%3Cproquest_pubme%3E18140346%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=196897455&rft_id=info:pmid/11529927&rfr_iscdi=true |